Cargando…
Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern
Rapid emergence of the SARS-CoV-2 variants has dampened the protective efficacy of existing authorized vaccines. Nanoparticle platforms offer a means to improve vaccine immunogenicity by presenting multiple copies of desired antigens in a repetitive manner which closely mimics natural infection. We...
Autores principales: | Khaleeq, Sara, Sengupta, Nayanika, Kumar, Sahil, Patel, Unnatiben Rajeshbhai, Rajmani, Raju S., Reddy, Poorvi, Pandey, Suman, Singh, Randhir, Dutta, Somnath, Ringe, Rajesh P., Varadarajan, Raghavan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961482/ https://www.ncbi.nlm.nih.gov/pubmed/36851560 http://dx.doi.org/10.3390/v15020346 |
Ejemplares similares
-
A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern
por: Ahmed, Shahbaz, et al.
Publicado: (2021) -
Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions
por: Mittal, Nidhi, et al.
Publicado: (2021) -
A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein
por: Khatri, Bhavesh, et al.
Publicado: (2022) -
Immunogenicity and Protective Efficacy of a Highly
Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain
Derivative
por: Malladi, Sameer Kumar, et al.
Publicado: (2021) -
Comparative Immunogenicity of Bacterially Expressed Soluble Trimers and Nanoparticle Displayed Influenza Hemagglutinin Stem Immunogens
por: Kar, Uddipan, et al.
Publicado: (2022)